News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Gangolli Julian S
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 10/06/2023 |
4
| Gangolli Julian S (Director) has filed a Form 4 on Outlook Therapeutics, Inc.|
Txns:
| Granted 370,282 options to buy
@ $0.24, valued at
$88.9k
|
|
| 07/03/2023 |
4
| Gangolli Julian S (Director) has filed a Form 4 on Krystal Biotech, Inc.|
Txns:
| Granted 6,800 options to buy
@ $117.4, valued at
$798.3k
|
|
| 05/05/2023 |
4
| Gangolli Julian S (Director) has filed a Form 4 on Revance Therapeutics, Inc.|
Txns:
| Granted 3,534 shares
@ $0
Granted 5,915 options to buy
@ $33.61, valued at
$198.8k
|
|
| 03/31/2023 |
4
| Gangolli Julian S (Director) has filed a Form 4 on Outlook Therapeutics, Inc.|
Txns:
| Granted 41,065 options to buy
@ $1.05, valued at
$43.1k
|
|
| 10/07/2022 |
4
| Gangolli Julian S (Director) has filed a Form 4 on Outlook Therapeutics, Inc.|
Txns:
| Granted 74,398 options to buy
@ $1.25, valued at
$93k
|
|
| 07/01/2022 |
4
| Gangolli Julian S (Director) has filed a Form 4 on Krystal Biotech, Inc.|
Txns:
| Granted 6,800 options to buy
@ $65.66, valued at
$446.5k
|
|
| 05/06/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/24/2022 |
4
| Gangolli Julian S (Director) has filed a Form 4 on Outlook Therapeutics, Inc.|
Txns:
| Granted 21,878 options to buy
@ $1.92, valued at
$42k
|
|
| 10/07/2021 |
4
| Gangolli Julian S (Director) has filed a Form 4 on Outlook Therapeutics, Inc.|
Txns:
| Granted 44,466 options to buy
@ $2.12, valued at
$94.3k
|
|
| 07/02/2021 |
4
| Gangolli Julian S (Director) has filed a Form 4 on Krystal Biotech, Inc.|
Txns:
| Granted 6,800 options to buy
@ $68, valued at
$462.4k
|
|
| 05/07/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/26/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/05/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/07/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/21/2020 |
4
| Gangolli Julian S (Director) has filed a Form 4 on Outlook Therapeutics, Inc.|
Txns:
| Granted 125,000 options to buy
@ $1.58, valued at
$197.5k
|
|
| 07/06/2020 |
4
| Gangolli Julian S (Director) has filed a Form 4 on Outlook Therapeutics, Inc.|
Txns:
| Granted 35,006 options to buy
@ $1.28, valued at
$44.8k
|
|
| 05/15/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/21/2020 |
4
| Gangolli Julian S (Director) has filed a Form 4 on Outlook Therapeutics, Inc.|
Txns:
| Granted 25,000 options to buy
@ $0.72, valued at
$18k
|
|
| 05/14/2019 |
4
| Gangolli Julian S (President, North America) has filed a Form 4 on GW PHARMACEUTICALS PLC|
Txns:
| Exercised 403,804 shares
@ $0.0013, valued at
$524.9
Exercised 75,369 shares
@ $10.61, valued at
$799.7k
Exercised 192,755 shares
@ $3.72, valued at
$717k
Sold 117,876 shares
@ $14.63, valued at
$1.7M
Sold 81,156 shares
@ $14.7, valued at
$1.2M
Sold 65,268 shares
@ $14.8, valued at
$966k
Sold 208,260 shares
@ $14.88, valued at
$3.1M
Sold 145,164 shares
@ $14.96, valued at
$2.2M
Sold 12,048 shares
@ $15.03, valued at
$181.1k
Sold 31,368 shares
@ $15.12, valued at
$474.3k
Sold 10,788 shares
@ $15.19, valued at
$163.9k
|
|
| 05/10/2019 |
4
| Gangolli Julian S (Director) has filed a Form 4 on Revance Therapeutics, Inc.|
Txns:
| Granted 4,500 shares
@ $0
Granted 9,000 options to buy
@ $12.82, valued at
$115.4k
|
|
| 03/06/2019 |
4
| Gangolli Julian S (Director) has filed a Form 4 on Krystal Biotech, Inc.|
Txns:
| Granted 20,000 options to buy
@ $22.75, valued at
$455k
|
|
| 02/28/2019 |
4
| Gangolli Julian S (President, North America) has filed a Form 4 on GW PHARMACEUTICALS PLC|
Txns:
| Exercised 11,256 shares
@ $0.0013, valued at
$14.6
Sold 5,952 shares
@ $12.45, valued at
$74.1k
Sold 48 shares
@ $12.37, valued at
$593.8
Exercised 11,256 options
@ $0 |
|
| 05/11/2018 |
4
| Gangolli Julian S (Director) has filed a Form 4 on Revance Therapeutics, Inc.|
Txns:
| Granted 3,000 shares
@ $0
Granted 6,000 options to buy
@ $29.15, valued at
$174.9k
|
|
| 05/12/2017 |
4
| Gangolli Julian S (Director) has filed a Form 4 on Revance Therapeutics, Inc.|
Txns:
| Granted 3,000 shares
@ $0
Granted 6,000 options to buy
@ $20.9, valued at
$125.4k
|
|
| 07/06/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 03/19/2015 |
4
| Gangolli Julian S (CVP & Pres, North America) has filed a Form 4 on ALLERGAN INC|
Txns:
| Gifted 20,078 shares
@ $0
Gifted 2,095 shares
@ $0
Granted 7,892 shares
@ $0
Disposed/sold 220 shares
@ $0
Disposed/sold 265 shares
@ $0
Disposed/sold 7,946 shares
@ $0
Disposed/sold 60,000 options to buy
@ $64.47, valued at
$3.9M
Disposed/sold 12,500 options to buy
@ $59.13, valued at
$739.1k
Disposed/sold 52,000 options to buy
@ $75.58, valued at
$3.9M
Disposed/sold 38,000 options to buy
@ $87.91, valued at
$3.3M
Disposed/sold 15,000 options to buy
@ $87.91, valued at
$1.3M
|
|
| 02/24/2015 |
4
| Gangolli Julian S (CVP & Pres, North America) has filed a Form 4 on ALLERGAN INC|
Txns:
| Paid exercise price by delivering 269 shares
@ $234, valued at
$62.9k
Granted 514 restricted stock units
@ $0
Exercised 514 restricted stock units
@ $0 |
|
| 02/19/2015 |
4
| Gangolli Julian S (CVP & Pres, North America) has filed a Form 4 on ALLERGAN INC|
Txns:
| Paid exercise price by delivering 1,150 shares
@ $230.15, valued at
$264.7k
|
|
| 03/07/2014 |
4
| Gangolli Julian S (CVP & Pres, North America) has filed a Form 4 on ALLERGAN INC|
Txns:
| Gifted 3,120 shares
@ $0
Gifted 3,120 shares
@ $0 |
|
| 02/25/2014 |
4
| Gangolli Julian S (CVP & Pres, North America) has filed a Form 4 on ALLERGAN INC|
Txns:
| Paid exercise price by delivering 1,880 shares
@ $125.07, valued at
$235.1k
Granted 40,729 options to buy
@ $125.07, valued at
$5.1M
|
|
| 12/30/2013 |
4
| Gangolli Julian S (CVP & Pres, North America) has filed a Form 4 on ALLERGAN INC|
Txns:
| Sold 15,000 shares
@ $110.17, valued at
$1.7M
Sold 37,500 shares
@ $110, valued at
$4.1M
Exercised 15,000 options to buy
@ $40.16, valued at
$602.4k
Exercised 37,500 options to buy
@ $59.13, valued at
$2.2M
|
|
| 03/04/2013 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 02/22/2013 |
4
| Gangolli Julian S (CVP & Pres, North America) has filed a Form 4 on ALLERGAN INC|
Txns:
| Paid exercise price by delivering 2,699 shares
@ $108.08, valued at
$291.7k
Granted 20,000 options to buy
@ $105.87, valued at
$2.1M
Granted 40,000 options to buy
@ $105.87, valued at
$4.2M
|
|
| 01/14/2013 |
4
| Gangolli Julian S (CVP & Pres, North America) has filed a Form 4 on ALLERGAN INC|
Txns:
| Gifted 401 shares
@ $0
Gifted 401 shares
@ $0 |
|
|
|
|